178 related articles for article (PubMed ID: 33093584)
1. Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury.
Minta K; Brinkmalm G; Al Nimer F; Thelin EP; Piehl F; Tullberg M; Jeppsson A; Portelius E; Zetterberg H; Blennow K; Andreasson U
Sci Rep; 2020 Oct; 10(1):18075. PubMed ID: 33093584
[TBL] [Abstract][Full Text] [Related]
2. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.
Grossetete M; Phelps J; Arko L; Yonas H; Rosenberg GA
Neurosurgery; 2009 Oct; 65(4):702-8. PubMed ID: 19834375
[TBL] [Abstract][Full Text] [Related]
3. Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.
Minta K; Jeppsson A; Brinkmalm G; Portelius E; Zetterberg H; Blennow K; Tullberg M; Andreasson U
Fluids Barriers CNS; 2021 May; 18(1):23. PubMed ID: 33985551
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury.
Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P
Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.
Minta K; Cullen NC; Nimer FA; Thelin EP; Piehl F; Clarin M; Tullberg M; Jeppsson A; Portelius E; Zetterberg H; Blennow K; Andreasson U
Clin Chem Lab Med; 2019 Sep; 57(10):1565-1573. PubMed ID: 30980710
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.
Minta K; Brinkmalm G; Thelin EP; Al Nimer F; Piehl F; Tullberg M; Jeppsson A; Portelius E; Zetterberg H; Blennow K; Andreasson U
Clin Chim Acta; 2021 Jan; 512():74-83. PubMed ID: 33275942
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
[TBL] [Abstract][Full Text] [Related]
8. Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans.
Roberts DJ; Jenne CN; Léger C; Kramer AH; Gallagher CN; Todd S; Parney IF; Doig CJ; Yong VW; Kubes P; Zygun DA
J Neurotrauma; 2013 Oct; 30(20):1727-36. PubMed ID: 23799281
[TBL] [Abstract][Full Text] [Related]
9. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
[TBL] [Abstract][Full Text] [Related]
10. Chemokines and matrix metalloproteinases in cerebrospinal fluid of patients with central nervous system complications caused by varicella-zoster virus.
Lind L; Eriksson K; Grahn A
J Neuroinflammation; 2019 Feb; 16(1):42. PubMed ID: 30777092
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of matrix metalloproteinases and their tissue inhibitors in the cerebrospinal fluid of patients with Alzheimer's disease.
Mroczko B; Groblewska M; Zboch M; Kulczyńska A; Koper OM; Szmitkowski M; Kornhuber J; Lewczuk P
J Alzheimers Dis; 2014; 40(2):351-7. PubMed ID: 24448781
[TBL] [Abstract][Full Text] [Related]
12. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury.
Manek R; Moghieb A; Yang Z; Kumar D; Kobessiy F; Sarkis GA; Raghavan V; Wang KKW
Mol Neurobiol; 2018 Jul; 55(7):6112-6128. PubMed ID: 29188495
[TBL] [Abstract][Full Text] [Related]
13. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
[TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
Duits FH; Hernandez-Guillamon M; Montaner J; Goos JD; Montañola A; Wattjes MP; Barkhof F; Scheltens P; Teunissen CE; van der Flier WM
J Alzheimers Dis; 2015; 48(3):711-20. PubMed ID: 26402072
[TBL] [Abstract][Full Text] [Related]
15. Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?
Sieber M; Dreßler J; Franke H; Pohlers D; Ondruschka B
J Forensic Leg Med; 2018 Apr; 55():65-73. PubMed ID: 29471249
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their tissue inhibitors in the serum and cerebrospinal fluid of patients with meningitis.
Tsai HC; Shi MH; Lee SS; Wann SR; Tai MH; Chen YS
Clin Microbiol Infect; 2011 May; 17(5):780-4. PubMed ID: 21521415
[TBL] [Abstract][Full Text] [Related]
17. A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans.
Roberts DJ; Jenne CN; Léger C; Kramer AH; Gallagher CN; Todd S; Parney IF; Doig CJ; Yong VW; Kubes P; Zygun DA
J Neurotrauma; 2013 Oct; 30(20):1717-26. PubMed ID: 23725031
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid dynamics in non-acute post-traumatic ventriculomegaly.
Lalou AD; Levrini V; Czosnyka M; Gergelé L; Garnett M; Kolias A; Hutchinson PJ; Czosnyka Z
Fluids Barriers CNS; 2020 Mar; 17(1):24. PubMed ID: 32228689
[TBL] [Abstract][Full Text] [Related]
19. RANTES levels in peripheral blood, CSF and contused brain tissue as a marker for outcome in traumatic brain injury (TBI) patients.
Albert V; Subramanian A; Agrawal D; Bhoi SK; Pallavi P; Mukhopadhayay AK
BMC Res Notes; 2017 Mar; 10(1):139. PubMed ID: 28340601
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Cerebrospinal Fluid Matrix Metalloproteinases Levels and Brain Amyloid Deposition in Mild Cognitive Impairment.
Sasaki Y; Kimura N; Aso Y; Yabuuchi K; Aikawa M; Matsubara E
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
